|
|
||||||||
2Michael Heidelberger Division of Immunology, Department of Pathology and Kaplan Cancer Center, New York University Medical Center, New York, NY 10016
In the final stages of thymic development, immature T cells undergo three distinct processes (positive selection, negative selection, and lineage commitment) that all depend on interactions of thymocyte TCRs with MHC molecules. It is currently thought that TCRs are preferentially restricted by either MHC class I or class II molecules. In this report, we present direct evidence that the TCR previously described as H-Y/H-2Db specific cross-reacts with H-2IAb if expressed in CD4+ cells. We also demonstrate an increase in thymocyte numbers in H-Y TCR-trangenic mice deficient in MHC class II, suggesting a relatively discrete form of negative selection by MHC class II compared with that induced by H-Y/H-2Db. We propose that inability to generate CD4+ T cells expressing H-Y TCR in different experimental settings may be due to tolerance to self-MHC class II. These results, therefore, support an intriguing possibility that tolerance to self may influence and/or interfere with the outcome of the lineage commitment.
This article has been cited by other articles:
![]() |
Q. Ge, P. D. Holler, V. S. Mahajan, T. Nuygen, H. N. Eisen, and J. Chen Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms PNAS, February 7, 2006; 103(6): 1822 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Eshima, H. Suzuki, and N. Shinohara Cross-Positive Selection of Thymocytes Expressing a Single TCR by Multiple Major Histocompatibility Complex Molecules of Both Classes: Implications for CD4+ versus CD8+ Lineage Commitment J. Immunol., February 1, 2006; 176(3): 1628 - 1636. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Logunova, C. Viret, L. A. Pobezinsky, S. A. Miller, D. B. Kazansky, J. P. Sundberg, and A. V. Chervonsky Restricted MHC-peptide repertoire predisposes to autoimmunity J. Exp. Med., July 5, 2005; 202(1): 73 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Serreze, T. M. Holl, M. P. Marron, R. T. Graser, E. A. Johnson, C. Choisy-Rossi, R. M. Slattery, S. M. Lieberman, and T. P. DiLorenzo MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice J. Immunol., January 15, 2004; 172(2): 871 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Morgan, C. T. Nugent, B. J. E. Raveney, and L. A. Sherman In a Transgenic Model of Spontaneous Autoimmune Diabetes, Expression of a Protective Class II MHC Molecule Results in Thymic Deletion of Diabetogenic CD8+ T Cells J. Immunol., January 15, 2004; 172(2): 1000 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santori, I. Arsov, M. Lili, and S. Vukmanovic Editing Autoreactive TCR Enables Efficient Positive Selection J. Immunol., August 15, 2002; 169(4): 1729 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santori, I. Arsov, and S. Vukmanovic Modulation of CD8+ T Cell Response to Antigen by the Levels of Self MHC Class I J. Immunol., May 1, 2001; 166(9): 5416 - 5421. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Lacorazza, C. Tucek-Szabo, L. V. Vasovic, K. Remus, and J. Nikolich-Zugich Premature TCR{{alpha}}{{beta}} Expression and Signaling in Early Thymocytes Impair Thymocyte Expansion and Partially Block Their Development J. Immunol., March 1, 2001; 166(5): 3184 - 3193. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |